The technology billionaire, Elon Musk, has announced a successful implantation of Neuralink's wireless brain chip in a human, marking a significant milestone.

The initial findings show promising neuron spikes, and the patient is reportedly recovering well. Neuralink's objective is to establish a connection between human brains and computers, aiming to address complex neurological conditions.

The company received approval from the US Food and Drug Administration (FDA) in May to conduct human trials, overcoming earlier challenges in obtaining regulatory clearance.

In a six-year study, a robotic system is employed to delicately insert 64 flexible threads, thinner than a human hair, into a region of the brain associated with "movement intention."

These threads enable the experimental implant, powered by a wirelessly chargeable battery, to record and transmit brain signals to an app for decoding the user's intended movements.

Elon Musk, sharing the news on his social media platform X (formerly Twitter), revealed that Neuralink's initial product, named Telepathy, aims to allow control of devices such as phones and computers through mere thought.

He emphasized its potential benefit for individuals who have lost limb functionality, envisioning enhanced communication for people like the late Stephen Hawking.

While Musk's involvement raises Neuralink's prominence, the field has other long-standing players.

Companies like Blackrock Neurotech, operating since 2004, and Precision Neuroscience, co-founded by a Neuralink co-founder, are also working on brain-computer interfaces.

The latter's implant, resembling a thin piece of tape, offers a simpler procedure for implantation via a "cranial micro-slit."

Several existing devices have demonstrated success in recent scientific studies, monitoring brain activity during speech attempts and decoding signals to aid communication.

The competition in the emerging field of brain-machine interfaces is intensifying, with different approaches and technologies vying for success.